J&J's consumer health spinout has a new name, Kenvue, and a modern look for its well-known portfolio of brands including Tylenol and Neutrogena.
J&J debuts Kenvue as new name for $15B consumer health business spinoff
Johnson & Johnson’s consumer health company has a new name, identity and purpose. Kenvue is a combination of “ken” meaning knowledge and “vue” a homonym of view, the company said on Wednesday.
The $15 billion consumer spinoff with household staple brands including Neutrogena, Tylenol, Band-Aid and a lineup of baby care products is set to become a separate publicly traded company by November 2023.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
